Bevacizumab plus chemotherapy in nonsquamous non‐small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B

BACKGROUND: Pleurodesis is the standard of care for non‐small cell lung cancer (NSCLC) patients with symptomatic malignant pleural effusion (MPE). However, there is no standard management for MPE uncontrolled by pleurodesis. Most patients with unsuccessful MPE control are unable to receive effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Noro, Rintaro, Kobayashi, Kunihiko, Usuki, Jiro, Yomota, Makiko, Nishitsuji, Masaru, Shimokawa, Tsuneo, Ando, Masahiro, Hino, Mitsunori, Hagiwara, Koichi, Miyanaga, Akihiko, Seike, Masahiro, Kubota, Kaoru, Gemma, Akihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327672/
https://www.ncbi.nlm.nih.gov/pubmed/32421226
http://dx.doi.org/10.1111/1759-7714.13472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327672/
https://www.ncbi.nlm.nih.gov/pubmed/32421226
http://dx.doi.org/10.1111/1759-7714.13472

Ejemplares similares